Englander Institute for Precision Medicine

Publications

Found 14 results
Author Title Type [ Year(Asc)]
Filters: Keyword is Cohort Studies  [Clear All Filters]
2023
Amin N, Liu J, Bonnechere B, MahmoudianDehkordi S, Arnold M, Batra R, Chiou Y-J, Fernandes M, M Ikram A, Kraaij R et al..  2023.  Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals.. JAMA Psychiatry. 80(6):597-609.
2022
Park J, Foox J, Hether T, Danko DC, Warren S, Kim Y, Reeves J, Butler DJ, Mozsary C, Rosiene J et al..  2022.  System-wide transcriptome damage and tissue identity loss in COVID-19 patients.. Cell Rep Med. 3(2):100522.
Brendel M, Getseva V, Assaad MAl, Sigouros M, Sigaras A, Kane T, Khosravi P, Mosquera JMiguel, Elemento O, Hajirasouliha I.  2022.  Weakly-supervised tumor purity prediction from frozen H&E stained slides.. EBioMedicine. 80:104067.
2021
Bauer A, Zierer A, Gieger C, Buyukozkan M, Müller-Nurasyid M, Grallert H, Meisinger C, Strauch K, Prokisch H, Roden M et al..  2021.  Comparison of genetic risk prediction models to improve prediction of coronary heart disease in two large cohorts of the MONICA/KORA study.. Genet Epidemiol. 45(6):633-650.
Zacharias HU, Hertel J, Johar H, Pietzner M, Lukaschek K, Atasoy S, Kunze S, Völzke H, Nauck M, Friedrich N et al..  2021.  A metabolome-wide association study in the general population reveals decreased levels of serum laurylcarnitine in people with depression.. Mol Psychiatry. 26(12):7372-7383.
Thorand B, Zierer A, Buyukozkan M, Krumsiek J, Bauer A, Schederecker F, Sudduth-Klinger J, Meisinger C, Grallert H, Rathmann W et al..  2021.  A Panel of 6 Biomarkers Significantly Improves the Prediction of Type 2 Diabetes in the MONICA/KORA Study Population.. J Clin Endocrinol Metab. 106(4):e1647-e1659.
2020
Vosoughi A, Zhang T, Shohdy KS, Vlachostergios PJ, Wilkes DC, Bhinder B, Tagawa ST, Nanus DM, Molina AM, Beltran H et al..  2020.  Common germline-somatic variant interactions in advanced urothelial cancer.. Nat Commun. 11(1):6195.
Cyrta J, Augspach A, De Filippo MRosaria, Prandi D, Thienger P, Benelli M, Cooley V, Bareja R, Wilkes D, Chae S-S et al..  2020.  Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.. Nat Commun. 11(1):5549.
Arnold M, Nho K, Kueider-Paisley A, Massaro T, Huynh K, Brauner B, MahmoudianDehkordi S, Louie G, M Moseley A, J Thompson W et al..  2020.  Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome.. Nat Commun. 11(1):1148.
Auguste A, Blanc-Durand F, Deloger M, Le Formal A, Bareja R, Wilkes DC, Richon C, Brunn B, Caron O, Devouassoux-Shisheboran M et al..  2020.  Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond Mutations: A Comprehensive Genomic Analysis.. Cells. 9(6)
2019
Conteduca V, Oromendia C, Eng KW, Bareja R, Sigouros M, Molina A, Faltas BM, Sboner A, Mosquera JMiguel, Elemento O et al..  2019.  Clinical features of neuroendocrine prostate cancer.. Eur J Cancer. 121:7-18.
2018
Do KTrinh, Wahl S, Raffler J, Molnos S, Laimighofer M, Adamski J, Suhre K, Strauch K, Peters A, Gieger C et al..  2018.  Characterization of missing values in untargeted MS-based metabolomics data and evaluation of missing data handling strategies.. Metabolomics. 14(10):128.
2017
Sailer V, Holmes EEva, Gevensleben H, Goltz D, Dröge F, Franzen A, Dietrich J, Kristiansen G, Bootz F, Schröck A et al..  2017.   DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.. Clin Epigenetics. 9:12.
2016
Goltz D, Holmes EEva, Gevensleben H, Sailer V, Dietrich J, Jung M, Röhler M, Meller S, Ellinger J, Kristiansen G et al..  2016.  CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients.. Oncotarget. 7(33):53309-53320.